Pamela E. Potter

1.8k total citations
47 papers, 1.5k citations indexed

About

Pamela E. Potter is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Pamela E. Potter has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cellular and Molecular Neuroscience, 23 papers in Molecular Biology and 20 papers in Pharmacology. Recurrent topics in Pamela E. Potter's work include Neuroscience and Neuropharmacology Research (25 papers), Cholinesterase and Neurodegenerative Diseases (20 papers) and Nicotinic Acetylcholine Receptors Study (11 papers). Pamela E. Potter is often cited by papers focused on Neuroscience and Neuropharmacology Research (25 papers), Cholinesterase and Neurodegenerative Diseases (20 papers) and Nicotinic Acetylcholine Receptors Study (11 papers). Pamela E. Potter collaborates with scholars based in United States, Hungary and Austria. Pamela E. Potter's co-authors include Norton H. Neff, James L. Meek, Thomas D. White, Israel Hanin, Lucia I. Sue, Douglas G. Walker, Thomas G. Beach, E. Sylvester Vizi, T. Celeste Napier and Heide Hörtnagl and has published in prestigious journals such as Brain Research, The FASEB Journal and Annals of the New York Academy of Sciences.

In The Last Decade

Pamela E. Potter

44 papers receiving 1.4k citations

Peers

Pamela E. Potter
Keith F. Martin United Kingdom
Dean R. Haubrich United States
Lawrence Manzino United States
P. Riederer Germany
J. T. Coyle United States
Jan N. Johannessen United States
Keith F. Martin United Kingdom
Pamela E. Potter
Citations per year, relative to Pamela E. Potter Pamela E. Potter (= 1×) peers Keith F. Martin

Countries citing papers authored by Pamela E. Potter

Since Specialization
Citations

This map shows the geographic impact of Pamela E. Potter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela E. Potter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela E. Potter more than expected).

Fields of papers citing papers by Pamela E. Potter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela E. Potter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela E. Potter. The network helps show where Pamela E. Potter may publish in the future.

Co-authorship network of co-authors of Pamela E. Potter

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela E. Potter. A scholar is included among the top collaborators of Pamela E. Potter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela E. Potter. Pamela E. Potter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, H., et al.. (2025). Vosoritide (Voxzogo) for Achondroplasia: A Review of Clinical and Real-World Evidence. Cureus. 17(7). e87983–e87983.
2.
Potter, Pamela E.. (2013). Curcumin: a natural substance with potential efficacy in Alzheimer’s disease. Journal of Experimental Pharmacology. 5. 23–23. 36 indexed citations
4.
Stanton, Patric K., et al.. (2009). Neuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13. Neuroreport. 20(13). 1193–1197. 18 indexed citations
5.
Newell, Amanda, Lucia I. Sue, Sarah Scott, et al.. (2003). Thiorphan-induced neprilysin inhibition raises amyloid β levels in rabbit cortex and cerebrospinal fluid. Neuroscience Letters. 350(3). 178–180. 20 indexed citations
6.
Beach, Thomas G., Douglas G. Walker, Pamela E. Potter, Lucia I. Sue, & Abraham Fisher. (2001). Reduction of cerebrospinal fluid amyloid β after systemic administration of M1 muscarinic agonists. Brain Research. 905(1-2). 220–223. 55 indexed citations
7.
Roher, Alex E., Yu‐Min Kuo, Pamela E. Potter, et al.. (2000). Cortical Cholinergic Denervation Elicits Vascular Aβ Deposition. Annals of the New York Academy of Sciences. 903(1). 366–373. 47 indexed citations
8.
Beach, Thomas G., Pamela E. Potter, Yu‐Min Kuo, et al.. (2000). Cholinergic deafferentation of the rabbit cortex: a new animal model of Aβ deposition. Neuroscience Letters. 283(1). 9–12. 53 indexed citations
9.
Potter, Pamela E.. (1999). Lesion of septal-hippocampal neurons with 192 IgG-saporin alters function of M1 muscarinic receptors. Neuropharmacology. 38(4). 579–586. 19 indexed citations
10.
Chiu, Fung‐Chow, Pamela E. Potter, & Renato Rozental. (1998). Purification of Human Fetal Hippocampal Neurons by Flow Cytometry for Transplantation. Methods. 16(3). 260–267. 5 indexed citations
11.
Satoh, Tetsuo, et al.. (1997). α2A subtype of presynaptic α2-Adrenoceptors modulates the release of [3H]-noradrenaline from rat spinal cord. Brain Research Bulletin. 42(2). 129–132. 39 indexed citations
12.
Potter, Pamela E., et al.. (1997). Modulation of hippocampal norepinephrine release by cholinergic agonists is altered by AF64A lesion. Brain Research Bulletin. 42(2). 153–160. 14 indexed citations
13.
Potter, Pamela E., et al.. (1991). Diphenylhydantoin attenuates hypoxia-induced release of [3H]glutamate from rat hippocampal slices. Brain Research. 558(1). 127–130. 18 indexed citations
14.
Hörtnagl, Heide, Pamela E. Potter, Ernst A. Singer, Gisela Kindel, & Israel Hanin. (1989). Clonidine Prevents Transient Loss of Noradrenaline in Response to Cholinergic Hypofunction Induced by Ethylcholine Aziridinium (AF64A). Journal of Neurochemistry. 52(3). 853–858. 16 indexed citations
15.
Napier, T. Celeste & Pamela E. Potter. (1989). Dopamine in the rat ventral pallidum/substantia innominata: Biochemical and electrophysiological studies. Neuropharmacology. 28(7). 757–760. 55 indexed citations
16.
Hörtnagl, Heide, Pamela E. Potter, Gisela Kindel, & Israel Hanin. (1989). Noradrenaline depletion protects cholinergic neurons in rat hippocampus against AF64A-induced damage. Journal of Neuroscience Methods. 27(2). 103–108. 10 indexed citations
17.
Potter, Pamela E., et al.. (1989). Effects of LF-14, THA and physostigmine in rat hippocampus and cerebral cortex. Neurochemistry International. 14(4). 433–438. 10 indexed citations
18.
Hörtnagl, Heide, et al.. (1988). Role of the aziridinium moiety in the in vivo cholinotoxicity of ethylcholine aziridinium ion (AF64A). Journal of Neuroscience Methods. 23(2). 107–113. 11 indexed citations
20.
Potter, Pamela E., et al.. (1978). Localized changes in blood-brain barrier permeability following the administration of antineoplastic drugs.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(9). 2930–4. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026